145 related articles for article (PubMed ID: 3535496)
1. Alpha interferon in the treatment of hematologic malignancies.
Roth MS; Foon KA
Am J Med; 1986 Nov; 81(5):871-82. PubMed ID: 3535496
[TBL] [Abstract][Full Text] [Related]
2. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
Foon KA; Roth MS; Bunn PA
Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
[TBL] [Abstract][Full Text] [Related]
3. Alpha-interferon treatment of cutaneous T cell lymphoma and chronic lymphocytic leukemia.
Foon KA; Bunn PA
Semin Oncol; 1986 Dec; 13(4 Suppl 5):35-9. PubMed ID: 3541217
[TBL] [Abstract][Full Text] [Related]
4. [Various aspects and results of therapy with interferon].
Niederle N
Arzneimittelforschung; 1988 Mar; 38(3A):449-53. PubMed ID: 2456071
[TBL] [Abstract][Full Text] [Related]
5. The hematologic malignancies. Leukemia, lymphoma, and myeloma.
Freireich EJ; Keating M; Cabanillas F; Barlogie B
Cancer; 1984 Dec; 54(11 Suppl):2741-50. PubMed ID: 6208991
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Philadelphia chromosome-positive patients.
Talpaz M; Kantarjian H; Kurzrock R; Trujillo JM; Gutterman JU
Ann Intern Med; 1991 Apr; 114(7):532-8. PubMed ID: 2001086
[TBL] [Abstract][Full Text] [Related]
7. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
8. The new alpha interferons.
Balmer CM
Drug Intell Clin Pharm; 1985 Dec; 19(12):887-93. PubMed ID: 3910384
[TBL] [Abstract][Full Text] [Related]
9. Clinical overview of alpha interferon. Studies and future directions.
Spiegel RJ
Cancer; 1987 Feb; 59(3 Suppl):626-31. PubMed ID: 3542185
[TBL] [Abstract][Full Text] [Related]
10. [Interferon-alpha in the treatment of hematologic neoplasms].
Aulitzky W; Gastl G; Tilg H; Troppmair J; Leiter E; Geissler D; Flener R; Huber C
Wien Med Wochenschr; 1986 Apr; 136(7-8):172-81. PubMed ID: 3524022
[TBL] [Abstract][Full Text] [Related]
11. Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma.
Steis RG; Foon KA; Longo DL
Cancer; 1987 Feb; 59(3 Suppl):658-63. PubMed ID: 10822466
[TBL] [Abstract][Full Text] [Related]
12. Alpha interferon: perspectives in the biotherapy of chronic myelogenous leukemia.
Terebelo HR
Oncol Nurs Forum; 1991; 18(1 Suppl):5-9. PubMed ID: 1997975
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of chronic myeloid leukemia with interferon].
Fülle HH; Dahmen E; Hellriegel KP
Onkologie; 1988 Aug; 11(4):177-83. PubMed ID: 3054669
[TBL] [Abstract][Full Text] [Related]
14. Therapy of essential thrombocythemia with alpha-interferon: results and prospects.
Lazzarino M; Vitale A; Morra E; Gagliardi A; Bernasconi P; Torromeo C; Inverardi D; Burgio VL; Castello A; Bernasconi C
Eur J Haematol Suppl; 1990; 52():15-21. PubMed ID: 2279539
[TBL] [Abstract][Full Text] [Related]
15. Interferon therapy of non-Hodgkin's lymphoma.
Foon KA; Roth MS; Bunn PA
Cancer; 1987 Feb; 59(3 Suppl):601-4. PubMed ID: 3492259
[TBL] [Abstract][Full Text] [Related]
16. Biologic response modifiers: the interferon alfa experience.
Koeller JM
Am J Hosp Pharm; 1989 Nov; 46(11 Suppl 2):S11-5. PubMed ID: 2481396
[TBL] [Abstract][Full Text] [Related]
17. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
[TBL] [Abstract][Full Text] [Related]
18. Biotherapy in clinical practice.
Figlin RA
Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hematologic diseases with alpha interferon].
Castaigne S
Bull Cancer; 1988; 75(9):859-62. PubMed ID: 3207895
[TBL] [Abstract][Full Text] [Related]
20. Current status of interferons in the treatment of cancer.
Hansen RM; Borden EC
Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
